These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 2455105

  • 1. A clinical pharmacological study of nifedipine and lisinopril alone and in combination.
    Lees KR, Meredith PA, Reid JL.
    J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S105-7. PubMed ID: 2455105
    [Abstract] [Full Text] [Related]

  • 2. Lisinopril and nifedipine: no acute interaction in normotensives.
    Lees KR, Reid JL.
    Br J Clin Pharmacol; 1988 Mar; 25(3):307-13. PubMed ID: 2833920
    [Abstract] [Full Text] [Related]

  • 3. Comparative pharmacokinetics and pharmacodynamics of lisinopril and enalapril, alone and in combination with propranolol.
    Bendtsen F, Henriksen JH.
    J Hum Hypertens; 1989 Jun; 3 Suppl 1():139-45. PubMed ID: 2550636
    [Abstract] [Full Text] [Related]

  • 4. A comparison of single doses of lisinopril and enalapril in hypertension.
    Dews I, Wiseman WT, al-Khawaja I, Stephens J, VandenBurg M.
    J Hum Hypertens; 1989 Jun; 3 Suppl 1():35-9. PubMed ID: 2550644
    [Abstract] [Full Text] [Related]

  • 5. Comparative trial of lisinopril and nifedipine in mild to severe essential hypertension.
    Mörlin C, Baglivo H, Boeijinga JK, Breckenridge AM, Clement D, Johnston GD, Klein W, Kramer R, Luccioni R, Meurer KA.
    J Cardiovasc Pharmacol; 1987 Jun; 9 Suppl 3():S49-52. PubMed ID: 2442552
    [Abstract] [Full Text] [Related]

  • 6. Comparative efficacy of lisinopril and nifedipine retard in essential hypertension: a double-blind, placebo-controlled trial.
    Richardson PJ, Meany TB, Johnston GD, Kondowe G, Grimmer SF, Breckenridge AM.
    J Cardiovasc Pharmacol; 1987 Jun; 10 Suppl 10():S96-8. PubMed ID: 2455154
    [Abstract] [Full Text] [Related]

  • 7. Lisinopril in essential hypertension: a six month comparative study with nifedipine.
    Richardson PJ, Meany B, Breckenridge AM, Grimmer SF, Johnston GD, Kondowe G.
    J Hum Hypertens; 1987 Dec; 1(3):175-9. PubMed ID: 2852252
    [Abstract] [Full Text] [Related]

  • 8. Comparative pharmacokinetics of enalapril and lisinopril, alone and with hydralazine.
    McLean AJ, Drummer OH, Smith HJ, Froomes P, McNeil JJ.
    J Hum Hypertens; 1989 Jun; 3 Suppl 1():147-51. PubMed ID: 2550637
    [Abstract] [Full Text] [Related]

  • 9. A 16-week, randomized, double-blind, placebo-controlled, crossover trial to quantify the combined effect of an angiotensin-converting enzyme inhibitor and a beta-blocker on blood pressure reduction.
    Wald DS, Law M, Mills S, Bestwick JP, Morris JK, Wald NJ.
    Clin Ther; 2008 Nov; 30(11):2030-9. PubMed ID: 19108791
    [Abstract] [Full Text] [Related]

  • 10. Lisinopril versus slow-release nifedipine in the treatment of mild to moderate hypertension: a multicentre study. The Cooperative Study Group.
    Witchitz S, Serradimigni A.
    J Hum Hypertens; 1989 Jun; 3 Suppl 1():29-33. PubMed ID: 2550643
    [Abstract] [Full Text] [Related]

  • 11. Pharmacodynamics and population pharmacokinetics of enalapril and lisinopril.
    Ajayi AA, Campbell BC, Kelman AW, Howie C, Meredith PA, Reid JL.
    Int J Clin Pharmacol Res; 1985 Jun; 5(6):419-27. PubMed ID: 3005181
    [Abstract] [Full Text] [Related]

  • 12. Combined inhibition of neutral endopeptidase and angiotensin-converting enzyme by sampatrilat in essential hypertension.
    Wallis EJ, Ramsay LE, Hettiarachchi J.
    Clin Pharmacol Ther; 1998 Oct; 64(4):439-49. PubMed ID: 9797801
    [Abstract] [Full Text] [Related]

  • 13. ACE inhibitors in mild to moderate hypertension: comparison of lisinopril and captopril administered once daily. French Cooperative Study Group.
    Gosse P, Dallocchio M, Gourgon R.
    J Hum Hypertens; 1989 Jun; 3 Suppl 1():23-8. PubMed ID: 2550642
    [Abstract] [Full Text] [Related]

  • 14. Effects on plasma angiotensin-converting enzyme activity and circulating renin of lisinopril and enalapril alone and in combination with propranolol in healthy volunteers.
    Hansen EF, Bendtsen F, Henriksen JH.
    Pharmacol Toxicol; 1999 Mar; 84(3):110-4. PubMed ID: 10193670
    [Abstract] [Full Text] [Related]

  • 15. Pharmacokinetics of enalapril and lisinopril in subjects with normal and impaired hepatic function.
    Hayes PC, Plevris JN, Bouchier IA.
    J Hum Hypertens; 1989 Jun; 3 Suppl 1():153-8. PubMed ID: 2550638
    [Abstract] [Full Text] [Related]

  • 16. Comparison of the effects of an angiotensin converting enzyme inhibitor and a calcium antagonist in hypertensive, macroproteinuric diabetic patients: a randomised double-blind study.
    O'Donnell MJ, Rowe BR, Lawson N, Horton A, Gyde OH, Barnett AH.
    J Hum Hypertens; 1993 Aug; 7(4):333-9. PubMed ID: 8410924
    [Abstract] [Full Text] [Related]

  • 17. A comparison of long acting nifedipine and enalapril in elderly hypertensives: a randomised, single-blind, cross-over study.
    Gilchrist NL, Nicholls MG, Ewer TC, Livesey JH, Sainsbury R.
    J Hum Hypertens; 1988 Jun; 2(1):33-9. PubMed ID: 2853227
    [Abstract] [Full Text] [Related]

  • 18. The clinical pharmacology of lisinopril.
    Case DE.
    J Hum Hypertens; 1989 Jun; 3 Suppl 1():127-31. PubMed ID: 2550635
    [Abstract] [Full Text] [Related]

  • 19. Effect of dietary sodium on angiotensin-converting enzyme (ACE) inhibition and the acute hypotensive effect of enalapril (MK-421) in essential hypertension.
    Jackson B, Cubela R, Johnston CI.
    J Hypertens; 1984 Aug; 2(4):371-7. PubMed ID: 6099390
    [Abstract] [Full Text] [Related]

  • 20. The pharmacokinetics of co-administered lisinopril and hydrochlorothiazide.
    Swaisland AJ.
    J Hum Hypertens; 1991 Dec; 5 Suppl 2():69-71. PubMed ID: 1665181
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.